{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:35:58Z","timestamp":1791639358586,"version":"4.3.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI136979"],"award-info":[{"award-number":["R01AI136979"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veteran\u2019s Affairs Medical Center"},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A patient with end-stage renal disease received 2 doses of dalbavancin for methicillin-resistant Staphylococcus aureus (MRSA) arteriovenous fistula infection and presented 5 weeks later with infective endocarditis secondary to vancomycin, daptomycin, and dalbavancin nonsusceptible MRSA. Resistance was associated with walK and scrA mutations, reduced long-chain lipid content, and reduced membrane fluidity.<\/jats:p>","DOI":"10.1093\/cid\/ciac341","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T07:20:31Z","timestamp":1651216831000},"page":"1641-1644","source":"Crossref","is-referenced-by-count":39,"title":["Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible\n                    <i>Staphylococcus aureus<\/i>\n                    in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization"],"prefix":"10.1093","volume":"75","author":[{"given":"Rutan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, University of Washington School of Pharmacy , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Polenakovik","sequence":"additional","affiliation":[{"name":"Veterans Affairs Medical Center , Dayton, Ohio , USA"},{"name":"Department of Medicine, Wright State University Boonshoft School of Medicine , Dayton, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael A","family":"Barreras Beltran","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Washington School of Pharmacy , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Waalkes","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Salipante","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, University of Washington School of Pharmacy , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-4098","authenticated-orcid":false,"given":"Brian J","family":"Werth","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Washington School of Pharmacy , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,1]]},"reference":[{"key":"2023053018542974600_ciac341-B1","doi-asserted-by":"crossref","first-page":"688357","DOI":"10.3389\/fmolb.2021.688357","article-title":"Synergy between beta-lactams and lipo-, glyco-, and lipoglycopeptides, is independent of the seesaw effect in methicillin-resistant Staphylococcus aureus","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2023053018542974600_ciac341-B2","doi-asserted-by":"crossref","first-page":"910.e1","DOI":"10.1016\/j.cmi.2020.08.025","article-title":"Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus","volume":"27","author":"Werth","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2023053018542974600_ciac341-B3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/jac\/dkz562","article-title":"Occurrence of cross-resistance and beta-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels","volume":"75","author":"Hines","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2023053018542974600_ciac341-B4","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.cmi.2017.07.028","article-title":"Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen","volume":"24","author":"Werth","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2023053018542974600_ciac341-B5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41426-018-0205-z","article-title":"Emergence of a dalbavancin induced glycopeptide\/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis","volume":"7","author":"Kussmann","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"2023053018542974600_ciac341-B6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jcpt.12580","article-title":"Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin","volume":"43","author":"Steele","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"2023053018542974600_ciac341-B7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/cid\/ciy279","article-title":"Dalbavancin as primary and sequential treatment for gram-positive infective endocarditis: 2-year experience at the general hospital of Vienna","volume":"67","author":"Tobudic","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023053018542974600_ciac341-B8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"2023053018542974600_ciac341-B9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/JCM.03385-14","article-title":"Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology","volume":"53","author":"Salipante","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2023053018542974600_ciac341-B10","first-page":"80","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3.","volume":"6","author":"Cingolani","year":"2012"},{"key":"2023053018542974600_ciac341-B11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.48.3.940-945.2004","article-title":"Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers","volume":"48","author":"Leighton","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2023053018542974600_ciac341-B12","doi-asserted-by":"crossref","first-page":"a026989","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved glycopeptide antibacterial drugs: mechanism of action and resistance","volume":"6","author":"Zeng","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2023053018542974600_ciac341-B13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/JB.186.4.1175-1181.2004","article-title":"Identification of genes controlled by the essential YycG\/YycF two-component system of Staphylococcus aureus","volume":"186","author":"Dubrac","year":"2004","journal-title":"J Bacteriol"},{"key":"2023053018542974600_ciac341-B14","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1128\/JB.00645-07","article-title":"New insights into the WalK\/WalR (YycG\/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus","volume":"189","author":"Dubrac","year":"2007","journal-title":"J Bacteriol"},{"key":"2023053018542974600_ciac341-B15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3389\/fmicb.2016.01326","article-title":"The response regulator YycF inhibits expression of the fatty acid biosynthesis repressor FabT in Streptococcus pneumoniae","volume":"7","author":"Mohedano","year":"2016","journal-title":"Front Microbiol"},{"key":"2023053018542974600_ciac341-B16","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JB.187.7.2357-2367.2005","article-title":"Evidence that the essential response regulator YycF in Streptococcus pneumoniae modulates expression of fatty acid biosynthesis genes and alters membrane composition","volume":"187","author":"Mohedano","year":"2005","journal-title":"J Bacteriol"},{"key":"2023053018542974600_ciac341-B17","doi-asserted-by":"crossref","first-page":"e1002359","DOI":"10.1371\/journal.ppat.1002359","article-title":"Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR","volume":"7","author":"Howden","year":"2011","journal-title":"PLoS Pathog"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac341\/43984013\/ciac341.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/9\/1641\/50491061\/ciac341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/9\/1641\/50491061\/ciac341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:55:01Z","timestamp":1685458501000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/9\/1641\/6576475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5,1]]},"published-print":{"date-parts":[[2022,10,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac341","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,5,1]]}}}